The Indian rupee had a volatile year in 2025, swinging to 91 from 84 against the US dollar. Here is…
The Indian rupee had a volatile year in 2025, swinging to 91 from 84 against the US dollar. Here is…
Defence electronics firm Tonbo Imaging has filed its DRHP with Sebi for an IPO via the OFS route. Here is…
The Indian rupee has staged a recovery from record lows. Here are the five factors that helped with the recent…
Colliers’ highlights five trends driving India’s 2026 office leasing surge, with Bengaluru leading growth—see five major trends to watch out…
The Indian rupee closed at 89.65 against the US dollar, slipping 0.4% from its Friday’s close.
Gold prices surged over 65% in 2025, hitting a record $4,400 per ounce. Here are five key reasons driving the…
The last week of December will see several key corporate actions including dividends, IPO launches, bonus issues, stock splits, rights…
The Indian rupee rebounded sharply to close at 89.27 against the US dollar following heavy intervention by RBI.
The Indian rupee breached the 91-per-dollar mark in 2025. Bank of Baroda explains four major triggers behind the currency’s fall.
The Indian rupee slips past the 91 mark against the US dollar, hitting fresh record lows. Analysts explain why the…
The Indian rupee ended at a fresh historic low of 90.73 against the US dollar . Here are the major…
Eastman Auto and Power (EAPL) has filed confidential IPO papers with SEBI. Here are 5 key details you should know…
The Indian rupee closed at a historic low of 90.41 against the US dollar, driven by delays in the India–US…
Steamhouse India files UDHRP with SEBI for its Rs 425 crore IPO. Here’s a breakdown of issue size, fund use,…
Corona Remedies IPO enters Day 2 of bidding with here are 10 key risks highlighted in the RHP that investors…
ICICI Prudential AMC IPO opens on December 12 with a Rs 10,602-crore offer for sale. Know the price band, lot…
Corona Remedies’ Rs 655 crore IPO opens on December 8 as a full Offer for Sale with a price band…
Aequs IPO opens Dec 3 with Rs 921 crore issue—review key details, GMP, and risk factors before subscribing!